Drug intelligence / Profile preview

alpha-glycerylphosphorylcholine + creatine + ashwagandha

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

This is a **combination dietary supplement** containing alpha-glycerylphosphorylcholine (Alpha-GPC), creatine, and ashwagandha. - **Alpha-GPC** serves as a highly bioavailable precursor for choline, contributing to the synthesis of acetylcholine, a neurotransmitter involved in memory, focus, muscle contraction, and overall cognitive function. Research shows potential benefits for cognitive performance, power output, and growth hormone production, possibly mediated by increased acetylcholine availability in the brain and neuromuscular junctions[1][2][6]. - **Creatine** is a naturally occurring compound often used in sports nutrition for its well-established ability to increase muscle power, strength, and lean body mass through replenishment of ATP (adenosine triphosphate) stores in muscle cells[1][2][5]. - **Ashwagandha** (Withania somnifera) is an adaptogenic herb, commonly used for its stress-reducing, anti-anxiety, and potential anabolic effects; it may also improve muscle strength and recovery, reduce cortisol, and support mitochondrial function[1][2][4]. This supplement is marketed for enhancing strength, power output, mental focus, and stress resilience, primarily in athletic and sports settings[1].

02

Targets

CHT1 (High-affinity choline transporter 1)NeuraminidaseAChR (Acetylcholine receptor)

Beyond the preview

Go deeper on alpha-glycerylphosphorylcholine + creatine + ashwagandha.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha-glycerylphosphorylcholine + creatine + ashwagandha.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call